Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Apply
Tegavivint
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step